Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/2000
10/31/2000US6139838 Tissue plasminogen activator medicinal composition
10/27/2000CA2307108A1 Process for production of mammalian cell lines, produced cell lines and their uses
10/26/2000WO2000063374A1 Synthetic transmembrane components
10/26/2000WO2000063372A1 Synthetic signalling molecules
10/26/2000WO2000063241A2 Methods and compositions for modulating an immune response
10/26/2000WO2000063230A2 49 human secreted proteins
10/26/2000WO2000063204A2 Substituted azoles
10/26/2000WO2000063178A1 Dibenzoazulene derivatives for treating thrombosis, osteoporosis, arteriosclerosis
10/26/2000WO2000063165A1 Mmp inhibitor
10/26/2000WO2000062799A1 Hcv combination therapy, containing ribavirin in association with antioxidants
10/26/2000WO2000062774A1 Methods of treating clinical diseases with isoflavones
10/26/2000WO2000062766A2 Uses of ppar-gamma agonists in neutrophil-induced diseases
10/26/2000WO2000039275A3 Multiple shear stress responsive elements (ssre) and methods of use thereof
10/26/2000WO2000035886A3 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
10/26/2000WO2000032188A3 Use of amtolmetin guacyl as an antiinflammatory drug
10/26/2000WO2000024770A9 Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
10/26/2000WO2000019976A9 Biodegradable terephthalate polyester-poly(phosphonate) and polyester-poly(phosphite) compositions, articles, and methods of using them
10/26/2000WO2000017191A3 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
10/26/2000WO2000016801A9 Methods of downmodulating the immune response to therapeutic proteins
10/26/2000WO2000006206A9 Compositions and methods for the treatment and diagnosis of cardiovascular disease
10/26/2000CA2370417A1 Substituted azoles
10/26/2000CA2370129A1 Methods and compositions for modulating an immune response
10/26/2000CA2370127A1 Novel method of treatment
10/26/2000CA2368784A1 Methods of treating clinical diseases with isoflavones
10/26/2000CA2367359A1 Dibenzoazulene derivatives for the treatment of thrombosis, osteoporosis, arteriosclerosis
10/26/2000CA2364209A1 49 human secreted proteins
10/25/2000EP1046410A2 Calcium and magnesium containing phosphate binding agent for the treatment of hyperphosphatemia
10/25/2000EP1046399A1 HCV combination therapy, containing ribavirin in association with antioxidants
10/25/2000EP1045908A2 Human urotensin ii
10/25/2000EP1045862A1 Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation
10/25/2000EP1045695A1 Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f 1? to treat peripheral vascular disease
10/25/2000CN1271386A Amino-terminally trancated RANTES as chemokine antagonists
10/25/2000CN1271385A Amino-terminally truncated MCP-2 as chemokine antagnosits
10/25/2000CN1271359A Novel compounds
10/25/2000CN1271347A 1,5-diphenylpypazole derivatives
10/25/2000CN1271279A Amide derivatives for the treatment of diseases mediated by cytokines
10/25/2000CN1057775C Anti-thrombus active peptide and preparation method thereof
10/25/2000CN1057685C Chinese medicine preparation for treating hemorrhoid and fistula
10/24/2000US6137002 Glycoprotein IIb/IIIa antagonists
10/24/2000US6136957 Antibodies which bind granulocyte-macrophane colony-stimulating factor receptor
10/24/2000US6136839 Using a sulfone or sulfoamide benzene compound
10/24/2000US6136800 Steroids
10/24/2000US6136323 Forming immunology response
10/24/2000CA2122930C Purified heparin fractions, method for obtaining them and pharmaceutical compositions containing them
10/24/2000CA2047702C Serpin resistant chymotrypsin superfamily proteases particularly pai-1 resistant t-pa, complementary inhibitor mutants; compositions; genes; expression
10/19/2000WO2000061779A1 49 human secreted proteins
10/19/2000WO2000061774A2 Bone morphogenic proteins
10/19/2000WO2000061755A2 Secreted human proteins
10/19/2000WO2000061754A2 Human proteins and polynucleotides encoding them
10/19/2000WO2000061748A1 48 human secreted proteins
10/19/2000WO2000061637A1 Erythropoietin receptor antibodies
10/19/2000WO2000061625A1 48 human secreted proteins
10/19/2000WO2000061620A1 49 human secreted proteins
10/19/2000WO2000061609A2 Prodrugs of thrombin inhibitors
10/19/2000WO2000061608A2 Low-molecular inhibitors of complement proteases
10/19/2000WO2000061583A1 Xanthine derivatives and analogs as cell signaling inhibitors
10/19/2000WO2000061577A1 Prodrugs of thrombin inhibitors
10/19/2000WO2000061555A1 Indigoid bisindole derivatives
10/19/2000WO2000061551A2 Pyrimidine-2-one derivatives as integrin receptor ligands
10/19/2000WO2000061542A1 Caspase inhibitors and the use thereof
10/19/2000WO2000061195A1 Benzodiazepine derivatives for imaging thrombi
10/19/2000WO2000061191A2 Heat stable coated colloidal iron oxides
10/19/2000WO2000061169A1 Pharmaceutical compositions of erythropoietin
10/19/2000WO2000061121A2 Use of molecular weight-amplified hirudin as an anticoagulant in extracorporeal renal replacement therapy
10/19/2000WO2000041505A3 Anthranilic acid derivatives
10/19/2000WO2000039290A8 Pharmaceutical formulation containing a microbial enzyme which digests hyaluronic acid
10/19/2000WO2000013702A9 Use of an angiogenic factor for the treatment of microvascular angiopathies
10/19/2000WO2000012720A8 Elongase genes and uses thereof
10/19/2000DE19916837A1 New di- or tetrahydro-benzoazulene derivatives, are integrin inhibitors useful e.g. for treating thrombosis, coronary heart disease, arteriosclerosis, tumors, osteoporosis or rheumatoid arthritis
10/19/2000CA2372171A1 Benzodiazepine derivatives for imaging thrombi
10/19/2000CA2370767A1 49 human secreted proteins
10/19/2000CA2370267A1 Prodrugs of thrombin inhibitors
10/19/2000CA2370189A1 48 human secreted proteins
10/19/2000CA2369981A1 Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using same
10/19/2000CA2369827A1 Separation of plasma components
10/19/2000CA2369670A1 Indigoid bisindole derivatives
10/19/2000CA2369619A1 Caspase inhibitors and the use thereof
10/19/2000CA2369378A1 Low-molecular inhibitors of complement proteases
10/19/2000CA2369096A1 Use of increased-molecular-weight hirudin as an anticoagulant in extracorporeal kidney replacement therapy
10/19/2000CA2368830A1 Prodrugs of thrombin inhibitors
10/19/2000CA2368049A1 Integrin receptor ligands
10/19/2000CA2365918A1 49 human secreted proteins
10/19/2000CA2365917A1 Bone morphogenic proteins
10/19/2000CA2365910A1 Human proteins and polynucleotides encoding them
10/19/2000CA2365905A1 48 human secreted proteins
10/19/2000CA2306039A1 Hcv combination therapy
10/18/2000EP1044975A1 Stable crystalline salts of 5-methyltetrahydrofolic acid
10/18/2000EP1044972A1 5,6,7-TRINOR-4,8-INTER-m-PHENYLENE PGI2 DERIVATIVE AND DRUGS CONTAINING THE SAME
10/18/2000EP1044211A1 36 human secreted proteins
10/18/2000EP1044210A1 Human dendriac and brainiac-3
10/18/2000EP1044017A1 Supplement for dialysis patients
10/18/2000EP1044009A2 Methods and compositions employing red rice fermentation products
10/18/2000EP0467932B1 Urokinase-type plasminogen activator receptor
10/18/2000CN1270591A Novel compounds
10/18/2000CN1270590A Novel compounds
10/18/2000CN1270035A Xiaogusan medicine
10/18/2000CN1057534C Erythropoietin analogs
10/18/2000CN1057522C Naphthalene derivs. as prostaglandin I2 agonists
10/18/2000CN1057458C Medicinal preparation for purpura
10/17/2000US6133315 Administering to treat pancreatitis, thrombosis, ischemia, stroke, restenosis, emphysema or inflammation in a mammal; compounds such as 2-chlorobenzenesulfonic acid 3-(3-amidinopropoxy)-5-methylphenyl ester hydrochloride
1 ... 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 ... 671